Literature DB >> 4029250

Effect of probenecid on isofezolac kinetics.

A Bannier, F Comet, J Soubeyrand, J L Brazier, F Chauliac.   

Abstract

The interaction between isofezolac and probenecid has been studied with the aid of a specific HPLC assay for isofezolac in plasma and urine. 8 healthy adult volunteers received a single 40 mg oral dose of isofezolac before and after 3 days of loading with 0.5 probenecid t.i.d. There was an increase in the maximum plasma isofezolac concentration from 2.44 to 3.38 micrograms X ml-1 when probenecid was given. The AUC of isofezolac in plasma increased from 6.73 to 11.28 micrograms X h X ml-1. After the last dose in a 7 day treatment with 40 mg isofezolac t.i.d., there was an increase in the maximum plasma isofezolac level from 2.84 to 4.96 micrograms X ml-1 when probenecid was given. The rate of absorption of isofezolac was not affected. An increase in the AUC of isofezolac in plasma was observed from 11.74 to 26.34 micrograms X h X ml-1. The major effect of probenecid on isofezolac metabolism was a 50% reduction in total isofezolac (free + conjugates) excreted inurine. Because of this interaction, patients given isofezolac combined with probenecid will have a higher steady-state plasma level of isofezolac than when probenecid is not administered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029250     DOI: 10.1007/bf00544363

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Study of two new non-steroid anti-inflammatory drugs having a pyrazole structure (LM 22070 and LM 22102).

Authors:  J Mizoule; G Le Fur; A Uzan
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-04

2.  On the mechanism of action of probenecid on renal tubular secretion.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

3.  Naproxen-probenecid interaction.

Authors:  R Runkel; E Mroszczak; M Chaplin; H Sevelius; E Segre
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

4.  Probenecid-clofibrate interaction.

Authors:  J R Veenendaal; P M Brooks; P J Meffin
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875

5.  The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.

Authors:  N Baber; L Halliday; R Sibeon; T Littler; M L Orme
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

6.  Effects of probenecid on ketoprofen kinetics.

Authors:  R A Upton; R L Williams; J N Buskin; R M Jones
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

7.  Determination of isofezolac in biological fluids by reversed-phase liquid column chromatography.

Authors:  A Bannier; J L Brazier
Journal:  J Chromatogr       Date:  1980-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.